From Silent Epidemic to Measurable Value
Rethinking Alzheimer’s Through a Health Systems Lens
17.11.25
Our latest article reframes Alzheimer’s disease (AD) as a health system risk multiplier, exploring the knock-on effects of the disease and its management on global health systems. Louise Hogg, our Market Access director, explores:
Download and read the paper to discover Ipsos’ commentary on the real-world evidence (RWE) and health economics and outcomes research (HEOR) opportunities in the Alzheimer’s disease space.